Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223522
Status:
COMPLETED
Last Update Posted:
2005-09-22
First Post:
2005-09-14
Brief Title:
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
The University of Texas Health Science Center at San Antonio
Study Overview
Official Title:
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to prospectively examine adherence to oral atypical antipsychotics in patients with schizophrenia We are psrticularly interested in examining the level of agreement among self-report physician impressions and objective measures of adherence We believe that physicians casemanagers and clients significantly overestimate the level of adherence
Detailed Description:
Fifty schizophrenia patients will be recruited at the time of their clinic visit to Tri-County MHMR Services and the El Paso Community MHMR Center Both physicians and patients will be asked to rate the patients medication adherence on their index clinic visit Initial ratings will also occur at this visit After filling their medication prescription all subjects will be given electronic medication caps that record each time and date their medication container is opened Patients will then be followed in the community for the next 12 weeks to observe actual adherence to medication from the index visit to the next successive clinic visit Every two weeks pills will be counted and data will be retrieved from the electronic medication caps During the first and last two weeks of study blood will be sampled on two randomly selected occasions approximately 72 hours apart Self-report and physician assessment of adherence symptom and attitudinal measures will be obtained a second time at the second clinic visit 12 weeks after the index visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 034-0013-002 | None | None | None |